SWOG News
Search and Filter
Results per Page:
What’s new in breast cancer research? SABCS20 goes virtual
Hutch scientists share findings on treatment, imaging, CAR T therapy, COVID-19’s impact on cancer patients and more
What's new in breast cancer research: #SABCS19 edition
Fred Hutch researchers share long-term follow-up data on WHI hormone study, anti-hormone side-effect strategies and more at San Antonio meeting
New data on cancer disparities in Washington
Health equity, patient voices and patient-engaged research hot topics at Value in Cancer Care Summit
How to boost cancer clinical trial participation
New study suggests loosening strict comorbidity criteria would open trials to thousands of previously exempt patients
Dr. James Dai receives $2.1M NCI grant for cancer biomarker research
Biostatistician plans to use funds to develop statistical models to further precision cancer prevention and treatment
Closing the rural-urban cancer survival gap
‘Guideline care’ in clinical trials erased cancer death-rate disparities
Dr. Yingqi Zhao receives SWOG Coltman Fellowship early-career award
She plans to use the funds to develop new surveillance and diagnostic strategies for immunotherapy trials
Acupuncture can curb AI-induced joint pain in some breast cancer patients
Large, randomized trial shows integrative approach relieves common side effect of estrogen-suppressing drug
Finasteride can reduce prostate cancer risk long term
Fred Hutch study taps big data to tease out extended cancer-prevention benefit of drug used for enlarged prostate, hair loss
Matching up cancer risk with reality
New examination of prostate cancer data identifies ‘detection bias’ in prostate studies
Good News: Global Oncology wins NCI grant; 1100 Eastlake building honored; Bish Paul essay in Science; Dr. Joseph Unger leads finasteride study
Celebrating faculty and staff achievements
Improving survival and reducing side effects in Hodgkin lymphoma
New data from cooperative trial suggest PET imaging could guide treatment
Cancer clinical trials: In defense of the negative result
Large cancer clinical trials that ‘fail’ carry just as much scientific oomph as positive findings, new study shows
Good News at Fred Hutch
Celebrating faculty and staff achievements
New hope for preserving fertility during breast cancer treatment
A medication that temporarily shuts down ovaries may offer women another option, new research shows
Vitamin E, selenium linked to increased prostate cancer risk
New Fred Hutch study raises caution about high doses of supplements
Ostronoff, Shankaran win two-year SWOG research grants
Fred Hutchinson Cancer Research Center investigators are among three recipients of $100,000 Coltman Fellowships from SWOG, formerly known as the Southwest Oncology Group
Intermittent hormone therapy for prostate cancer inferior to continuous therapy
Cathy Tangen contributes to international study, finding on again-off again prostate cancer treatment has quality of life benefits, but continuous therapy improves overall survival
Lower income cancer patients less likely to join clinical trials
Joseph Unger-led study finds poor patients stymied by financial, logistical concerns, blocking representation and access to latest therapies
Press Lab's Till wins SWOG award
Brian Till, research associate, studies mantle cell lymphoma